Karyopharm Therapeutics Inc (KPTI) is near the middle in its industry group according to InvestorsObserver. KPTI gets an overall rating of 36. That means it scores higher than 36 percent of stocks. Karyopharm Therapeutics Inc gets a 35 rank in the Biotechnology industry. Biotechnology is number 73 out of 148 industries.
KPTI has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on KPTI!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 36 would rank higher than 36 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Karyopharm Therapeutics Inc Stock Today?
Karyopharm Therapeutics Inc (KPTI) stock is higher by 3.75% while the S&P 500 has fallen -0.97% as of 11:04 AM on Tuesday, Sep 26. KPTI has gained $0.04 from the previous closing price of $1.20 on volume of 670,914 shares. Over the past year the S&P 500 is higher by 17.52% while KPTI has fallen -70.52%. KPTI lost -$1.47 per share the over the last 12 months.
Click Here to get the full Stock Report for Karyopharm Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
